• Who are EuroPrEP? EuroPrEP started as clinicians and advocates working to prevent HIV throughout Europe, most of whom also provide care and support to people living with HIV and hepatitis C. • What does EuroPrEP want? To include pre-exposure prophylaxis (PrEP) in our national HIV prevention programmes. The most commonly used drug, Truvada, costs about 500 euros for a month when purchased from Gilead (more than 10 times what it costs to make it). • Why are we signing this petition? We want Gilead to be a good partner and reduce the price of drug when used for prevention. They will still make a profit, but reducing the price will help to persuade governments they can afford to invest in this new tool.